Lexeo Therapeutics, Inc. (LXEO)

Lexeo Therapeutics Statistics

Total Valuation

LXEO has a market cap or net worth of $399.68 million. The enterprise value is $214.00 million.

Market Cap	399.68M
Enterprise Value	214.00M

Important Dates

The last earnings date was Monday, May 11, 2026, before market open.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

LXEO has 78.52 million shares outstanding. The number of shares has increased by 98.55% in one year.

Current Share Class	78.52M
Shares Outstanding	78.52M
Shares Change (YoY)	+98.55%
Shares Change (QoQ)	+6.32%
Owned by Insiders (%)	0.24%
Owned by Institutions (%)	75.24%
Float	47.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.63
P/TBV Ratio	1.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.16, with a Debt / Equity ratio of 0.03.

Current Ratio	14.16
Quick Ratio	13.61
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,164.11

Financial Efficiency

Return on equity (ROE) is -54.75% and return on invested capital (ROIC) is -36.34%.

Return on Equity (ROE)	-54.75%
Return on Assets (ROA)	-32.50%
Return on Invested Capital (ROIC)	-36.34%
Return on Capital Employed (ROCE)	-41.41%
Weighted Average Cost of Capital (WACC)	12.45%
Revenue Per Employee	n/a
Profits Per Employee	-$1.48M
Employee Count	59
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +89.22% in the last 52 weeks. The beta is 1.53, so LXEO's price volatility has been higher than the market average.

Beta (5Y)	1.53
52-Week Price Change	+89.22%
50-Day Moving Average	6.07
200-Day Moving Average	7.15
Relative Strength Index (RSI)	35.56
Average Volume (20 Days)	719,174

Short Selling Information

The latest short interest is 13.07 million, so 16.64% of the outstanding shares have been sold short.

Short Interest	13.07M
Short Previous Month	12.60M
Short % of Shares Out	16.64%
Short % of Float	27.49%
Short Ratio (days to cover)	13.19

Income Statement

Revenue	n/a
Gross Profit	-62.33M
Operating Income	-97.79M
Pretax Income	-87.50M
Net Income	-87.50M
EBITDA	-97.18M
EBIT	-97.79M
Earnings Per Share (EPS)	-$1.33

Balance Sheet

The company has $193.04 million in cash and $7.37 million in debt, with a net cash position of $185.68 million or $2.36 per share.

Cash & Cash Equivalents	193.04M
Total Debt	7.37M
Net Cash	185.68M
Net Cash Per Share	$2.36
Equity (Book Value)	231.50M
Book Value Per Share	3.12
Working Capital	186.67M

Cash Flow

In the last 12 months, operating cash flow was -$97.99 million and capital expenditures -$432,000, giving a free cash flow of -$98.42 million.

Operating Cash Flow	-97.99M
Capital Expenditures	-432,000
Depreciation & Amortization	601,000
Net Borrowing	-495,000
Free Cash Flow	-98.42M
FCF Per Share	-$1.25

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LXEO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-98.55%
Shareholder Yield	-98.55%
Earnings Yield	-21.89%
FCF Yield	-24.63%

Analyst Forecast

The average price target for LXEO is $18.88, which is 262.28% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.88
Price Target Difference	262.28%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1